10H-phenothiazine exerts beneficial effects in spinal muscular atrophy in vitro and in vivo models
Daniela Maria Rasà, Serena Stanga, Pamela Santonicola, Nadia Mazzarella, Antonella Camera, Ilenia Matino, Giuseppina Zampi, Marina Boido, Elia Di Schiavi, Alessandro Vercelli · 2025
Read 10H-phenothiazine exerts beneficial effects in spinal muscular atrophy in vitro and in vivo models by Daniela Maria Rasà, Serena Stanga, Pamela Santonicola, Nadia Mazzarella, Antonella Camera, Ilenia Matino, Giuseppina Zampi, Marina Boido, Elia Di Schiavi, Alessandro Vercelli (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12756266.txt.
Description
Daniela Rasà and nine co-authors test a repurposed drug for spinal muscular atrophy in a study from two thousand twenty-five. The disease kills motor neurons after mutation of the SMN1 gene. Approved drugs raise the missing protein, but results depend on timing and severity, so add-on options are wanted.
Their screen used cortical neurons from a mouse model of the disease, which showed poor survival and altered shape. Known protective compounds rescued those traits, validating the setup. A drug called 10H-phenothiazine, known for nerve protection in other diseases, also rescued survival and shape in the neurons. The effect held in a worm model of the disease. The authors propose the drug for further study as a companion therapy.
Catalog record
| CREATOR | Daniela Maria Rasà, Serena Stanga, Pamela Santonicola, Nadia Mazzarella, Antonella Camera, Ilenia Matino, Giuseppina Zampi, Marina Boido, Elia Di Schiavi, Alessandro Vercelli |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |